Share Price30 Dec 2025 09:54
Actually rather pleased how the share price has settled after the reaction to SGC phase 1b and look forward to IND approval any day now and the beginning of the AVA6103 trial which will finally allow AVACTA to call itself a pipeline biotech company if 6103 can anywhere near replicate animal studies it should be very lucrative I do expect Mr Hughes to do another raise probably end of Q1 but with 435m shares in issue I have always based my calculations on 500m shares in issues good luck all